Primary graft dysfunction: lessons learned about the first 7... : Current Opinion in Organ
Transplantation Primary graft dysfunction: lessons learned about the first 72 h after lung …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has been
associated with acute respiratory distress syndrome (ARDS) and in some cases with …

Extracorporeal membrane oxygenation (ECMO) for adult respiratory failure has significantly
increased, with longer duration ECMO support required in severe hypoxemia. We sought to …

Venovenous extracorporeal membrane oxygenation (VV-ECMO) may be a lifesaving rescue
therapy for patients with severe coronavirus disease 2019 (COVID-19). However, little is …

Extracorporeal support (ECMO) is indicated in severe heart or lung failure with 80% risk of
mortality. In experienced centers, overall survival to discharge ranges from 40% in cardiac …

The use of veno-venous extracorporeal membrane oxygenation (VV ECMO) in adults with
respiratory failure has steadily increased during the past decade. Recent literature has …

Since the first successful case report in 1972, extracorporeal life support or extracorporeal
membrane oxygenation (ECMO) has become a standard approach for severe respiratory …

Current and future status of extracorporeal life support for... : Current Opinion in Critical Care
Current and future status of extracorporeal life support for respiratory failure in adults : Current …

OBJECTIVES: To examine trends in utilization and outcomes among patients with the acute
respiratory distress syndrome (ARDS) requiring prolonged venovenous extracorporeal …

Abstract According to the Extracorporeal Life Support Organization, the average duration of
veno-venous extracorporeal membrane oxygenation (VV ECMO) in adults with acute …